462 related articles for article (PubMed ID: 11585779)
1. Antifungal susceptibility testing: practical aspects and current challenges.
Rex JH; Pfaller MA; Walsh TJ; Chaturvedi V; Espinel-Ingroff A; Ghannoum MA; Gosey LL; Odds FC; Rinaldi MG; Sheehan DJ; Warnock DW
Clin Microbiol Rev; 2001 Oct; 14(4):643-58, table of contents. PubMed ID: 11585779
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts.
Arthington-Skaggs BA; Motley M; Warnock DW; Morrison CJ
J Clin Microbiol; 2000 Jun; 38(6):2254-60. PubMed ID: 10834985
[TBL] [Abstract][Full Text] [Related]
3. Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms.
Espinel-Ingroff A; Pfaller M; Messer SA; Knapp CC; Killian S; Norris HA; Ghannoum MA
J Clin Microbiol; 1999 Mar; 37(3):591-5. PubMed ID: 9986817
[TBL] [Abstract][Full Text] [Related]
4. In vitro antifungal activities of bis(alkylpyridinium)alkane compounds against pathogenic yeasts and molds.
Chen SC; Biswas C; Bartley R; Widmer F; Pantarat N; Obando D; Djordjevic JT; Ellis DH; Jolliffe KA; Sorrell TC
Antimicrob Agents Chemother; 2010 Aug; 54(8):3233-40. PubMed ID: 20530227
[TBL] [Abstract][Full Text] [Related]
5. Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
Lass-Flörl C; Mayr A; Perkhofer S; Hinterberger G; Hausdorfer J; Speth C; Fille M
Antimicrob Agents Chemother; 2008 Oct; 52(10):3637-41. PubMed ID: 18694949
[TBL] [Abstract][Full Text] [Related]
6. Trends in antifungal susceptibility testing using CLSI reference and commercial methods.
Cantón E; Espinel-Ingroff A; Pemán J
Expert Rev Anti Infect Ther; 2009 Feb; 7(1):107-19. PubMed ID: 19622060
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of in vitro antifungal susceptibility testing.
Espinel-Ingroff A
Rev Esp Quimioter; 2000 Jun; 13(2):161-6. PubMed ID: 10918088
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi.
Espinel-Ingroff A
J Clin Microbiol; 2001 Apr; 39(4):1360-7. PubMed ID: 11283057
[TBL] [Abstract][Full Text] [Related]
9. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
Warnock DW; Johnson EM; Rogers TR
J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
[TBL] [Abstract][Full Text] [Related]
11. In vitro antifungal susceptibility testing.
Hoffman HL; Pfaller MA
Pharmacotherapy; 2001 Aug; 21(8 Pt 2):111S-123S. PubMed ID: 11501985
[TBL] [Abstract][Full Text] [Related]
12. In vitro antifungal susceptibility methods and clinical implications of antifungal resistance.
Espinel-Ingroff A; Warnock DW; Vazquez JA; Arthington-Skaggs BA
Med Mycol; 2000; 38 Suppl 1():293-304. PubMed ID: 11204157
[TBL] [Abstract][Full Text] [Related]
13. Antifungal susceptibility testing. New technology and clinical applications.
Pfaller MA; Yu WL
Infect Dis Clin North Am; 2001 Dec; 15(4):1227-61. PubMed ID: 11780273
[TBL] [Abstract][Full Text] [Related]
14. Antifungal drug resistance in pathogenic fungi.
Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Sensititre YeastOne colorimetric microdilution panel and the NCCLS broth microdilution method for antifungal susceptibility testing against Candida species.
Bernal S; Aller AI; Chávez M; Valverde A; Serrano C; Gutiérrez MJ; Quindós G; Martín Mazuelos E
Chemotherapy; 2002 Mar; 48(1):21-5. PubMed ID: 11901252
[TBL] [Abstract][Full Text] [Related]
16. In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species.
Guinea J; Peláez T; Recio S; Torres-Narbona M; Bouza E
Antimicrob Agents Chemother; 2008 Apr; 52(4):1396-400. PubMed ID: 18212101
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard.
Barchiesi F; Colombo AL; McGough DA; Rinaldi MG
J Clin Microbiol; 1994 Oct; 32(10):2494-500. PubMed ID: 7814488
[TBL] [Abstract][Full Text] [Related]
18. Development of reference procedures for broth microdilution antifungal susceptibility testing of yeasts with standardized endpoint determination.
Makimura K; Sudo T; Kudo M; Uchida K; Yamaguchi H
Microbiol Immunol; 1998; 42(1):55-9. PubMed ID: 9525781
[TBL] [Abstract][Full Text] [Related]
19. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.
Pfaller MA; Messer SA; Woosley LN; Jones RN; Castanheira M
J Clin Microbiol; 2013 Aug; 51(8):2571-81. PubMed ID: 23720791
[TBL] [Abstract][Full Text] [Related]
20. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
Espinel-Ingroff A
J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
